Rachel Ames

Company: RAPT Therapeutics

Job title: Senior Scientist - Discovery Biology

Seminars:

Utilizing Tumor Models to Overcome Immune Resistance Mechanisms & Support Checkpoint Inhibitor Therapeutic Assessments 1:45 pm

Discussing the role of Treg in immune resistance mechanisms to checkpoint inhibitors and cell therapies Reiterating role of CCR4 in the recruitment and accumulation of Treg in the tumor microenvironment Spotlighting updates on this work over the last 12 monthsRead more

day: Conference Day One - Track 1 - Post Lunch